Welcome to our dedicated page for Maximus news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on Maximus stock.
Maximus, Inc. (NYSE: MMS) is frequently in the news as a strategic partner to government and a provider of tech-enabled government services. Company announcements focus on contracts with U.S. federal agencies, U.S. states, and selected international programs, as well as updates on financial performance, capital allocation, and technology capabilities. This news page aggregates those disclosures so readers can follow how Maximus’ government-focused business evolves over time.
News about Maximus often highlights new or renewed contracts and program awards. Recent examples include agreements to support state-based health insurance marketplaces, such as enrollment and premium billing services for the Massachusetts Health Connector, and a renewed contract with Pennsylvania’s Department of Human Services to administer the Pennsylvania Enrollment Assistance Program, including expanded support for Children’s Health Insurance Program recipients. Federal sector news has featured a Joint Cyber Command & Control Readiness contract with the U.S. Air Force, covering engineering analysis, software modification, maintenance, and enhancement of cyber command and control systems.
Investors and observers can also find earnings releases and financial updates here. Maximus regularly reports segment performance for U.S. Federal Services, U.S. Services, and Outside the U.S., along with commentary on clinical program volumes, technology initiatives, margins, and free cash flow. The company also issues announcements on dividends and stock purchase program authorizations, reflecting its capital deployment approach.
Technology and cybersecurity developments are another recurring theme. Maximus has reported achieving Cybersecurity Maturity Model Certification (CMMC) Level 2, underscoring its ability to meet U.S. Department of Defense cybersecurity standards. Other news covers digital solutions such as member portals, multichannel engagement tools, and AI-based training for contact center staff. For anyone tracking MMS news, this page offers a centralized view of contract wins, program milestones, financial results, and technology-related updates tied to the company’s role in public sector service delivery.
Maximus (MMS) reported Q1 FY2023 financial results, with revenue increasing 8.5% to $1.25 billion and organic growth at 10.3%. Diluted EPS was $0.65, with adjusted EPS at $0.94. Due to the scheduled restart of Medicaid redeterminations, the company raised its FY23 revenue guidance to $4.85-$5.0 billion and adjusted EPS guidance to $4.00-$4.30. U.S. Services revenue rose 13.7% to $439.5 million, while the operating margin decreased to 8.6%. The cash dividend of $0.28 per share will be paid on February 28, 2023. Maximus remains focused on capturing growth in government services amid a recovery from pandemic-related challenges.
Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, scheduled for payment on February 28, 2023. Shareholders of record on February 15, 2023 will receive this dividend. As a prominent provider of government services globally, Maximus aims to enhance public service delivery through innovative business process management and technology solutions.
Maximus (NYSE: MMS) will release its financial results for the three months ended December 31, 2022, after market close on February 8, 2023. A conference call will follow on February 9, 2023, at 9:00 a.m. ET, where shareholders can submit questions via email. The call will be accessible to the public through a webcast and by phone. Maximus is a global leader in government services, focusing on improving public service delivery through innovative solutions and operational excellence.
Maximus (NYSE: MMS) has secured a $100 million contract with the Centers for Disease Control and Prevention (CDC) for one base year plus four option years. The contract aims to enhance the CDC-INFO program, providing vital health information to Americans. Maximus will utilize its technology and operational expertise to improve service delivery, especially post-COVID-19. The company has previously supported the CDC-VAX program during the pandemic, earning multiple awards for its efforts.
Maximus (NYSE: MMS) announced it will release its financial results for the fiscal year and quarter ending September 30, 2022, after market close on November 21, 2022. A conference call will follow on November 22, 2022, at 9:00 a.m. ET. Shareholders can submit questions for management via email until one hour prior to the call. The event will be accessible to the public through a webcast and by phone.
Maximus (NYSE:MMS) has announced the transition of Dr. Arvenita W. Cherry to the role of President of the Maximus Foundation, effective October 1. She succeeds Dr. John Boyer, who served for 17 years and will remain as Chairman until his retirement later this fiscal year. The Maximus Foundation is dedicated to supporting community and healthcare initiatives, recently distributing $2 million in grants to 167 nonprofits in the U.S. Dr. Cherry aims to align the foundation’s focus with the company’s diversity, equity, and inclusion strategies.
Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, set to be paid on November 30, 2022. Shareholders must be on record by November 15, 2022 to qualify for this dividend. This move highlights Maximus's commitment to returning income to its shareholders, reflecting the company's financial health and operational stability.
Maximus (NYSE: MMS) has secured a new contract valued at
Maximus (NYSE: MMS) reported a revenue decline of $118 million for Q3 FY2022, totaling $1.13 billion, impacted by a $413 million reduction in COVID-19 response work. Despite this, organic growth in the U.S. Federal Services Segment and a pipeline of signed contracts totaling $4.02 billion highlight future growth potential. Diluted EPS stood at $0.51, affected by an $11.7 million write-down. Full-year guidance remains unchanged for revenue at $4.6 billion, while EPS is projected between $2.85 and $3.05. A quarterly dividend of $0.28 per share will be paid on August 31, 2022.
Maximus (NYSE: MMS) will release its financial results for the three and nine months ending June 30, 2022, on August 3, 2022, after market close. A conference call will follow on August 4 at 9:00 a.m. ET. Shareholders can submit questions to management before the call by emailing IR@maximus.com. To listen, participants can join via webcast or phone: 877.407.8289 (Domestic) / +1.201.689.8341 (International). A recording will be available post-call.